Carbapenem-resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: Keep an eye on the ball
- PMID: 33242674
- PMCID: PMC7682477
- DOI: 10.1016/j.jgar.2020.11.004
Carbapenem-resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: Keep an eye on the ball
Abstract
Here we report on seven intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS) who developed positive rectal swabs and invasive infections due to carbapenemase-producing Klebsiella pneumoniae (CP-Kp). Notwithstanding the infection prevention measures introduced during the COVID-19 pandemic and changes in the hospitalised population, attention to CP-Kp infections must remain high, especially in the critically ill setting.
Keywords: Antimicrobial resistance; COVID-19; Carbapenem-resistant Klebsiella pneumonia; Carbapenemase; Infection control; Superinfection.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
References
-
- Zheng Z., Chen R., Li Y. The clinical characteristics of secondary infection of lower respiratory in severe acute respiratory syndrome. Chin J Respir Crit Care Med. 2003;2:270–274.
-
- European Centre for Disease Prevention and Control (ECDC) ECDC; 2019. Surveillance of Antimicrobial Resistance in Europe 2018.https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobi...
